GuiCom
13June2024

The role of diet in Inflammatory Bowel Disease

Emma Halmos, D-ECCO Committee Member, Hannah Gordon, GuiCom Chair and Richard Hansen, P-ECCO Committee Member


Emma Halmos
© ECCO
Hannah Gordon
© ECCO
Richard Hansen
© ECCO

Diet in Inflammatory Bowel Disease has become a hot topic in recent years, pushed forward by advances in our understanding of the microbiome and the promise of nutrition as therapy, particularly in Crohn’s Disease. One of the most important questions in clinic (and yet the hardest to answer) remains “What can I eat?” or variations of the same. The reason this question is so difficult to answer is the enormous complexity in how diet overlays IBD and also the lack of high-quality scientific studies addressing this specific problem.

Posted in ECCO News, Committee News, Volume 19, Issue 2, GuiCom, P-ECCO, D-ECCO

18April2024

Report on the updated ECCO Guidelines on Therapeutics in Crohn’s Disease

Hannah Gordon, GuiCom Chair and Michel Adamina, GuiCom Member


Hannah Gordon
© ECCO

Michel Adamina
© ECCO

The ECCO Guidelines for the management of Crohn’s Disease are among the most influential guidelines informing and guiding patient care worldwide. They are updated every 4 years and their latest iteration is about to be published following a plenary presentation at the recent ECCO Congress in Stockholm.

Posted in ECCO News, Committee News, GuiCom, Volume 19, Issue 1

18December2023

Introducing Johan Burisch as a new GuiCom Member

Torsten Kucharzik, GuiCom Chair

Torsten Kucharzik
© ECCO

GuiCom has developed important and world-wide recognised guidelines on the Diagnosis and Management of IBD. In order to create standardised guidelines of the highest quality, regular rotation and recruitment of highly experienced candidates is crucial. It is my great pleasure to introduce Johan Burisch, who will become a new GuiCom Member at the beginning of 2024. Johan was selected from a large group of excellent applicants for this position.

Posted in ECCO News, Committee News, GuiCom, Volume 18, Issue 4

26October2023

Report on the update of the ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

Hannah Gordon, GuiCom Member

Hannah Gordon
© ECCO

The second ECCO Guideline on Malignancy in IBD was published in JCC late last year, supported by working group leads Livia Biancone, Gionata Fiorino, Kostas Katsanos and Uri Kopylov. The ethos of this guideline was to couple evidence-based medicine with provision of practical advice, with a view to enhancing patient care worldwide. We worked alongside the ECCO Guidelines Team to undertake systematic reviews for each statement, selecting topics that are frequently relevant to patients with IBD as well as those which generate debate in the MDT.

Posted in ECCO News, Committee News, GuiCom, Volume 18, Issue 3

26October2023

Report on the update of the ECCO Guidelines on Inflammatory Bowel Disease and Malignancies (Copy)

Hannah Gordon, GuiCom Member

Hannah Gordon
© ECCO

The second ECCO Guideline on Malignancy in IBD was published in JCC late last year, supported by working group leads Livia Biancone, Gionata Fiorino, Kostas Katsanos and Uri Kopylov. The ethos of this guideline was to couple evidence-based medicine with provision of practical advice, with a view to enhancing patient care worldwide. We worked alongside the ECCO Guidelines Team to undertake systematic reviews for each statement, selecting topics that are frequently relevant to patients with IBD as well as those which generate debate in the MDT.

Posted in ECCO News, Committee News, GuiCom, Volume 18, Issue 3

15June2023

Report on the Update of the Guideline on Extraintestinal Manifestations in IBD

Torsten Kucharzik, GuiCom Chair

Torsten Kucharzik 
© ECCO

Up to 50% of patients with IBD suffer from extraintestinal manifestations (EIMs), which may impact every body system. EIMs are a source of considerable morbidity, and even mortality in the case of primary sclerosing cholangitis or venous thromboembolic events. Broadly, EIMs can be categorised as those resulting from inflammatory pathology at distant sites, the consequences of IBD and treatment, or wider associations. The underlying pathophysiology of extraintestinal inflammation is not fully understood. The systemic consequences of IBD lead to broader associations, including venous thromboembolic events and anaemia. Whether these are strictly EIMs is debated, but they result in great health burdens for our patients. 

Posted in ECCO News, Committee News, GuiCom, Volume 18, Issue 2

27April2023

New GuiCom Member introduction: Henit Yanai

Tim Raine, SciCom Member

Tim Raine 
© ECCO

In stepping down as the Chair of GuiCom, it is my absolute pleasure to welcome and introduce our newest member of the committee, Henit Yanai. Henit is the director of the IBD centre at the Rabin Medicine Centre in Petach Tikva, Israel and is also a faculty member at the Department of Gastroenterology and Liver Disease, Tel Aviv University. But in addition to her long and distinguished list of accomplishments, I’ve also had the pleasure of getting to know Henit through ECCO as a friend. Most recently, Henit was the Chair of the ECCO Educational Committee, which she led through the challenges and disruptions of the COVID-19 pandemic. She has also previously served as the National Representative to ECCO for Israel. She has organised the ECCO Advanced Course, where generations of the brightest and best of new IBD talent have benefited from her dynamic leadership and teaching.

Posted in ECCO News, Committee News, GuiCom, Volume 18, Issue 1

19December2022

Report on the ECCO Topical Review: Roadmap to optimal peri-operative care in IBD

Shaji Sebastian, ClinCom Chair and Antonino Spinelli, ECCO Member


Shaji Sebastian
© ECCO


Antonino Spinelli
© ECCO

It is well known that the outcomes of surgery, and especially of IBD surgery, are not merely dependent on the operative procedure but are influenced by a number of factors before, during and after surgery. The multidisciplinary team involved in the care of IBD patients has the opportunity to optimise patient care and status prior to surgery to ensure optimal outcomes and reduce the risk of complications.

Posted in ECCO News, Committee News, ClinCom, GuiCom, Volume 17, Issue 4

15June2022

New GuiCom Members

Michel Adamina & Javier Gisbert, GuiCom Members

Michel Adamina
© ECCO

Javier Gisbert
© ECCO

The ECCO Guidelines Committee (GuiCom) is welcoming two new committee members. Both are already well known in the ECCO Family. Michel Adamina was the former chair of S-ECCO and Javier Gisbert was ClinCom member in the past.  

Posted in ECCO News, Committee News, GuiCom, Volume 17, Issue 2

28April2022

Guidelines on Therapeutics in Ulcerative Colitis – Report on the UC Guidelines

Tim Raine, GuiCom Chair

Tim Raine 
© ECCO

At the ECCO Congress 2022, Yves Panis and I had the great pleasure to present the new ECCO Guidelines on Therapeutics in Ulcerative Colitis. This work has been published as two papers in JCC: one dealing with the medical aspects of UC management, and one dealing with surgical strategies and the management of patients with acute severe UC. The guidelines were produced by a team of 33 clinicians and six patients, drawn from a total of 23 countries and supported by a group of professional methodologists, a librarian and, of course, the staff of the ECCO Office, including the indomitable Dauren Ramankulov. Yves and I were joined by Glen Doherty and Antonino Spinelli as co-ordinators of this large effort.

Posted in ECCO News, Committee News, GuiCom, Volume 17, Issue 1